Express Pharma

Lupin appoints Nicholas Hart as President – Specialty for US Business

1

He has over 25 years of experience in specialty business, strategic and commercial operations

Lupin has announced the appointment of Nicholas (Nick) Hart as President – Specialty for its US business. Reportedly, Hart will lead the specialty strategic business unit in the US and will be responsible for Lupin’s specialty brand business growth strategy, P&L and organisation.

Hart has over 25 years of experience in specialty business, strategic and commercial operations. Most recently, Hart was the Business Unit Head for Reproductive Health at Ferring Pharmaceuticals. Prior to Ferring, he served as Senior VP of Sales and Marketing at URL Pharma. He has held positions of increasing responsibility in Commercial Operations, Corporate Strategy and Business Development. Hart holds a Bachelor’s of Science from The United States Military Academy at West Point and a MBA from New York University’s Stern School of Business.

Commenting on the appointment, Vinita Gupta, CEO, Lupin said, “We are delighted to welcome Nick to Lupin at a crucial time as we prepare to launch Solosec in the US market and accelerate efforts to build our Specialty business. His knowledge and experience in the industry will be valuable for our growth aspirations in the US market.”

Hart will be based in Baltimore, Maryland in the US, and will report to Vinita Gupta.

Comments are closed.